Sapient Capital LLC bought a new position in shares of Novo Nordisk A/S (NYSE:NVO – Free Report) during the fourth quarter, HoldingsChannel.com reports. The firm bought 631,609 shares of the company’s stock, valued at approximately $65,340,000. Novo Nordisk A/S accounts for approximately 1.7% of Sapient Capital LLC’s portfolio, making the stock its 10th biggest position. […]